What is the treatment for acute compression fractures?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Acute Compression Fractures

Conservative medical management is the initial treatment for acute compression fractures, consisting of analgesics (NSAIDs first-line, cautious opioid use), early mobilization, and optional bracing for 2-12 weeks, with vertebral augmentation (vertebroplasty or kyphoplasty) reserved for patients who fail conservative therapy after 3 months or require parenteral narcotics. 1, 2

Initial Conservative Management (First 3 Months)

Pain Control

  • NSAIDs are first-line analgesics for pain management in acute compression fractures 1
  • Opioids should be used cautiously due to risks of sedation, falls, decreased physical conditioning, and nausea—particularly problematic in elderly patients 1
  • Calcitonin 200 IU (nasal or suppository) for 4 weeks provides clinically important pain reduction at 1,2,3, and 4 weeks in acute presentations 3, 4
  • Most patients achieve spontaneous pain resolution within 6-8 weeks without intervention 1, 5

Mobilization Strategy

  • Early mobilization is critical to prevent complications including decreased bone mineral density, muscle strength loss, deep venous thrombosis, cardiovascular/respiratory deconditioning, and increased mortality 1, 2
  • Avoid prolonged bed rest—it causes rapid bone loss, muscle weakness, glucose intolerance, urinary complications, anxiety, depression, and creates a vicious cycle of deconditioning 1, 2, 5
  • Bracing may be used but shows equivalent outcomes to non-braced approaches 2

Vertebral Augmentation Indications (After 3 Months)

Vertebral augmentation should be offered when conservative therapy fails, defined as: 1

  • Pain refractory to oral medications after 3 months of conservative treatment 1
  • Contraindication to pain medications 1
  • Requirement for parenteral narcotics or hospital admission 1
  • Development of spinal deformity or pulmonary dysfunction 1

Evidence for Vertebral Augmentation

  • Vertebroplasty and kyphoplasty provide immediate and considerable improvement in pain and mobility compared to continued conservative therapy 1, 6
  • In the VERTOS II trial, vertebroplasty resulted in mean VAS score reduction of -5.2 at 1 month versus -2.7 with conservative treatment (difference 2.6, p<0.0001), with benefits sustained at 1 year 6
  • 70% of vertebroplasty patients showed statistically significant pain reduction and improved physical functioning at 24 hours, with 24% able to cease all analgesia after 24 hours (versus 0% in conservative treatment group) 1
  • Meta-analyses demonstrate improvements in pain intensity, vertebral height, sagittal alignment, functional capacity, and quality of life with vertebral augmentation 1

Timing Considerations

  • Studies show vertebral augmentation is superior to placebo for pain reduction in fractures <6 weeks duration 1
  • However, fractures >12 weeks show equivalent benefit to those <12 weeks, suggesting fracture age does not independently affect outcomes 1
  • In VERTOS II, 40% of conservatively treated patients had no significant pain relief after 1 year despite higher-class prescription medications 1

Vertebroplasty vs. Kyphoplasty

  • Both procedures are equally effective in substantially reducing pain and disability 1
  • Kyphoplasty shows superior improvement in vertebral height restoration and kyphotic angle correction with less cement leakage 1
  • Kyphoplasty costs approximately 2.5 times more than vertebroplasty with no clear superiority in pain outcomes 5

Surgical Consultation Indications

Immediate surgical referral is required for: 1, 2, 3, 5

  • Any neurological deficits 1, 2, 3
  • Frank spinal instability 1, 3
  • Significant spinal deformity (junctional kyphosis, retropulsion) 1
  • Spinal cord compression 3

Concurrent Osteoporosis Management

Initiate osteoporosis pharmacotherapy immediately to prevent additional fractures: 3, 5

  • Ibandronate or strontium ranelate specifically recommended for preventing additional symptomatic fractures 3, 5
  • 20% risk of another vertebral fracture within 12 months after the first fracture 5
  • Ensure adequate calcium intake (1000-1200 mg/day) and vitamin D supplementation (800 IU/day) 3

Critical Pitfalls to Avoid

  • Do not prescribe prolonged bed rest—causes deconditioning, bone loss, and increased mortality 1, 2, 3, 5
  • Avoid overuse of narcotics—leads to sedation, falls, decreased physical conditioning, and adverse drug reactions in >70% of patients (>10% severe reactions in elderly) 1, 2, 3
  • Do not delay osteoporosis pharmacotherapy—high risk of subsequent fractures 5
  • Obtain MRI if symptoms change or imaging is >3 months old to identify new fractures that may be overlooked on plain radiographs 1, 5
  • Perform adequate neurological examination to avoid missing unstable fractures requiring urgent surgical intervention 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of T8 Compression Fracture

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment for T10 Compression Fracture

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Calcitonin for treating acute and chronic pain of recent and remote osteoporotic vertebral compression fractures: a systematic review and meta-analysis.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2012

Guideline

Treatment of Osteoporosis with Lumbar Compression Fracture

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.